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Abstract: Mansonellosis is a filarial disease caused by three species of filarial (nematode) 
parasites (Mansonella perstans, Mansonella streptocerca, and Mansonella ozzardi) that use 
humans as their main definitive hosts. These parasites are transmitted from person to person by 
bloodsucking females from two families of flies (Diptera). Biting midges (Ceratopogonidae) 
transmit all three species of Mansonella, but blackflies (Simuliidae) are also known to play a role 
in the transmission of M. ozzardi in parts of Latin America. M. perstans and M. streptocerca are 
endemic in western, eastern, and central Africa, and M. perstans is also present in the neotropical 
region from equatorial Brazil to the Caribbean coast. M. ozzardi has a patchy distribution in Latin 
America and the Caribbean. Mansonellosis infections are thought to have little pathogenicity and 
to be almost always asymptomatic, but occasionally causing itching, joint pains, enlarged lymph 
glands, and vague abdominal symptoms. In Brazil, M. ozzardi infections are also associated with 
corneal lesions. Diagnosis is usually performed by detecting microfilariae in peripheral blood 
or skin without any periodicity. There is no standard treatment at present for mansonellosis. The 
combination therapy of diethylcarbamazine plus mebendazole for M. perstans microfilaremia is 
presently one of the most widely used, but the use of ivermectin has also been proven to be very 
effective against microfilariae. Recently, doxycycline has shown excellent efficacy and safety when 
used as an antimicrobial against endosymbiotic Wolbachia bacteria harbored by some strains of 
M. perstans and M. ozzardi. Diethylcarbamazine and ivermectin have been used effectively to 
treat M. streptocerca infection. There are at present no estimates of the disease burden caused by 
mansonellosis, and thus its importance to many global health professionals and policy makers 
is presently limited to how it can interfere with diagnostic tools used in modern filarial disease 
control and elimination programs aimed at other species of filariae.
Keywords: mansonellosis, filariasis, M. perstans, M. ozzardi, M. streptocerca, neglected disease
Introduction
Mansonellosis is a filarial disease caused by various species of the genus Mansonella 
(Nematoda; Filarioidea; Onchocercidae) that use humans as their primary definitive 
hosts.1 By most modern definitions, there are just three filarial species considered 
responsible for causing human mansonellosis: Mansonella perstans, Mansonella 
streptocerca, and Mansonella ozzardi.1–5 Other Mansonella spp., like the chimpanzee 
parasite Mansonella rodhaini, occasionally infect humans, and some can use humans 
as definitive hosts,6–9 producing patent infections with circulating microfilariae. How-
ever, they are rare infections in humans in comparison with other primates, and by 
convention they are not considered to cause mansonellosis.1–5
As M. ozzardi was originally the only parasite of the Mansonella genus known to 
infect humans,10 the term “mansonellosis” and its synonym “mansonelliasis” were, 
until the mid-1980s, applied only to infections caused by this one species.11–15 The 
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modern use of the term1–5 began only after Orihel and Eber-
hard revised the genus Mansonella and added M. perstans 
and M. streptocerca.16,17 Prior to this, a number of systems 
of nomenclature were used to describe Mansonella parasite 
infections,18–24 eg, mansonellosis was usually restricted to 
infections caused by M. ozzardi19,20 and the terms “per-
stans filariasis” and “streptocerciasis” were often used to 
describe infections with M. perstans and M. streptocerca, 
respectively.18,21–24
Among the known human filarial infections, mansonellosis 
is probably the most prevalent23,25 but nevertheless the least 
studied, and can be considered the most neglected filariasis. Cer-
tainly, it is more prevalent and more neglected than other filarial 
diseases like lymphatic filariasis, onchocerciasis, and loiasis. 
It can even probably be considered one of the most neglected 
of all the tropical diseases, as it is subject to more neglect than 
schistosomiasis, taeniasis, echinococcosis, or rabies. 1–5
The three species of Mansonella parasite which cause 
mansonellosis in humans vary in biological, clinical, and 
epidemiological characteristics (Table 1).1–5,18,23–25 The life 
cycles for all three species are similar, involving develop-
ment in two hosts: an insect and a primate.4,15,25–27 Humans 
are the only known natural vertebrate host for M. ozzardi, 
but other primates can serve as natural hosts for M. perstans 
and M. streptocerca.2,28 All of the known insect vectors of 
mansonellosis are from the Diptera taxonomic grouping. The 
known vectors of M. perstans and M. streptocerca are from 
the biting-midge genus Culicoides. M. ozzardi, however, is 
not exclusively transmitted by Culicoides.15,26,27,29 A range of 
non-Culicoides Ceratopogonidae biting midges and black-
flies from the genus Simulium are known to be capable of 
transmitting M. ozzardi (Table 1).15,26,27,29
Females of all known vectors of mansonellosis consume 
blood meals in order for their eggs to mature.26,27 Microfilariae 
are ingested by the vector when a female vector takes a blood 
meal from an infected host. The microfilariae penetrate the 
insect’s gut and go through several maturation stages in the 
thoracic flight muscles over 6–12 days before migrating to 
the head and proboscis, from where they can be transferred 
to a primate when the vector takes its next blood meal.4,26,27 
During the blood meal, the third-stage (infective) filarial 
larvae actively break out of the mouthparts and penetrate into 
skin via the bite wound before migrating and maturing into 
adult worms. Males and females mate, and female worms 
begin to produce unsheathed microfilariae that circulate in 
the blood (M. perstans and M. ozzardi) or diffuse into the 
skin (M. streptocerca and M. ozzardi) of the primate host.4,26,27 
Practical diagnostic guides often describe all three species 
as having aperiodic microfilariae that circulate in peripheral 
blood or skin throughout the day and night,30 although reports 
of cryptic periodicity for both M. perstans and M. ozzardi 
exist.4,31,32
Most of what is known of mansonellosis and the geo-
graphic distribution of Mansonella parasites is based on 
the morphological identification of microfilariae recovered 
from blood or skin-snip samples.23 With adult filarial para-
sites, almost impossible to recover, even accounts of “new 
species” of Mansonella or Mansonella-like parasites have 
often been based solely on the morphological characteristics 
of microfilariae.33–36 The species-diagnostic characters of 
microfilariae are sometimes difficult to see, and can vary 
greatly with sample preservation, mounting, and staining 
procedures,4–38 and hence microfilariae are easily misidenti-
fied.39,40 This has resulted in a number of questionable “new” 
Mansonella species being described,33–36 some controversial 
filarial parasite-distribution maps (generated by Mansonella 
parasites being confused with other filarial parasites and 
vice versa),39,40 inappropriate clinical treatments,39 and even 
dubious clinical symptoms being attributed to mansonellosis 
infections.41 For example, there has only ever been one very 
tentative report of M. perstans encountered in the cerebrospi-
nal fluid of patients. The report concerned patients from the 
Zambezi valley region of Zimbabwe,41 and has subsequently 
been attributed to a zoonotic filariasis,7,42,43 but there are a 
number of published papers where M. perstans is described 
as occasionally causing severe neurological symptoms.15,44–47
Following the development of filarial parasite-diagnostic 
polymerase chain reaction (PCR) assays, many ambiguities 
concerning species’ distribution and “new species” have 
been resolved, and most modern filarial parasite research, 
including mansonellosis research, now suffers from far 
fewer parasite-identification uncertainties than used to be 
the case.48–53 Almost all of these assays use mitochondrial or 
rDNA target sequences, and were developed from molecu-
lar systematic studies (see “Diagnosis” section), which 
used DNA sequences from these regions to constructed 
molecular filarial parasite phylogenies.48–57 Although these 
mitochondrial and rDNA phylogenetic studies and more 
recent multilocus sequence typing challenged traditional 
morphology-based phylogenies of the species within the 
family Onchocercidae,58 none has hitherto challenged the 
morphology-based genus Mansonella proposed by Eberhard 
and Orihel in 1984, from which the modern use of the term 
“mansonellosis” has arisen.16,17,50,54–60
Later molecular phylogenies investigated the origins of 
the filarial endosymbiont Wolbachia, which infects many 
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(though not all) filarial parasites.61–64 Data from these studies 
suggested that filarial parasites had acquired Wolbachia endo-
symbionts several times independently during the evolution 
of Onchocercidae.62–64 These Wolbachia endosymbionts have 
important roles in the pathology of onchocerciasis and lym-
phatic filariasis, and are also necessary for the reproduction 
and development of filarial parasites that cause these diseases. 
This has made them an important target for therapeutics.65 
Table 1 Main characteristics of Mansonella perstans, Mansonella ozzardi, and Mansonella streptocerca
M. perstans M. streptocerca M. ozzardi
Microfilaria tail Blunt, rounded tail, body
Nuclei extend to tip of tail
Hooked shape
Body nuclei extend to tip of tail
Long, thin, pointed tail
Body nuclei do not extend to tip of tail
Sheath in microfilariae Unsheathed Unsheathed Unsheathed
Microfilariae: 
periodicity and 
localization
Aperiodic microfilariae
Blood
Aperiodic microfilariae
Skin of the upper trunk and 
shoulder girdle
Non-periodic microfilariae
Blood and skin
Microfilaria: length × 
diameter
200×4–5 mm 180–240×3–5 mm 163–203×3–5 mm
Adults measurements ♂ 3.5–4.5 cm, ♀ 5–8 cm ♂ 1.3–1.8 cm, ♀ 2.7 cm ♂ 2.4–2.8 cm, ♀ 3.2–8.1 cm
Adults localization Serous body cavities, mainly 
peritoneal, but may also appear 
subcutaneously
Subcutaneous tissues of the 
dermis
Thoracic cavity and mesenteries of the 
peritoneal cavity
V
ec
to
r Africa Culicoides spp. (biting midges) Culicoides spp.(biting midges)
Central America •	 Simulium sanguineum (Panama)
South America Culicoides spp. (biting midges) Simuliidae
•	 Simulium exiguum (Argentina); 
S. amazonicum (Venezuela, Colombia, 
and Brazilian Amazon); S. argentiscutum 
(Colombia and Brazilian Amazon); 
S. oyapockense (Colombia, Venezuela, 
and Brazil); S. sanguineum (Colombia); 
S. guyanensis and S. sanchezi (Venezuela); 
S. minusculum (Guyana)
Ceratopogonidae
•	 Culicoides insinuatus (Colombia); 
C. guttatus (Guyana, Suriname and 
Venezuela); C. paraensis (French Guiana, 
Argentina and Bolivia); C. debilipalpis 
(Bolivia and Argentina); C. lahillei 
(Argentina)
Caribbean •	 C. furens (Haiti and St Vincent); 
C. barbosai (Haiti); C. paraensis? 
(St Vincent); C. phlebotomus (Trinidad); 
Leptoconops bequaerti (Haiti)
Geographical 
distribution
Central and west Africa, South 
America
Central and west Africa, western 
Uganda
Latin America and Caribbean islands
Reported clinical 
symptoms
Often asymptomatic
Itching, pruritus, joint pains, 
enlarged lymph glands, Calabar 
swelling, neurological manifestations
Often asymptomatic
Dermatitis, pruritus, rash, 
papular skin, inguinal adenopathy, 
occasional dizziness
Often asymptomatic
Moderate fever, headache, articular pain, 
rash, sensation of coldness in legs, foot 
edema and face edema, keratitis, or corneal 
opacity
Treatment Diethylcarbamazine + mebendazole: 
200 mg/12 hours + 100–200 mg/day 
× 21 days
Mebendazole: 100 mg/12 hours × 
30 days
Doxycycline: 200 mg/day × 6 weeks
Diethylcarbamazine: 6 mg/kg/day 
× 12 days
Ivermectin: 150 µg/kg, single 
dose; not active against the adult 
worm
Ivermectin: 200 µg/kg, single dose
Not active against the adult worm
 
R
es
ea
rc
h 
an
d 
Re
po
rts
 in
 T
ro
pi
ca
l M
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
19
4.
80
.2
29
.2
44
 o
n 
20
-S
ep
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Research and Reports in Tropical Medicine 2018:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
12
Ta-Tang et al
The Wolbachia bacteria that infect M. ozzardi and M. perstans 
appear to share a common origin, but are genetically very 
distinct (belonging to the F superclade of Wolbachia) from 
the Wolbachia known to cause disease pathologies.64 It is 
presently not clear if what is known about other filarial Wolba-
chia can be safely extrapolated to the Mansonella Wolbachia 
endosymbionts and if they have a hitherto-uncharacterized 
role in mansonellosis pathology or indeed what their role in 
Mansonella-parasite development and reproduction is.65,66 
However, in one clinical trial in Mali, antibiotic treatment 
with doxycycline was seen to provide sustained clearance 
of M. perstans parasitemias 12 months following treatment, 
suggesting that Wolbachia may have an important role in the 
reproduction and survival of adult worms.67
Wolbachia from M. perstans cannot be easily detected, 
and some M. perstans parasites may not be infected.66–69 
It has been proposed that Mansonella parasites may have 
acquired their F-clade Wolbachia (the only Wolbachia 
superclade found in both arthropod and filarial worm hosts) 
more recently than other filariae, and it may not be an 
essential symbiont for some Mansonella spp. and strains.66 
Consistent with this is the notion that M. perstans may be a 
species complex, and a potential new species or subspecies 
of M. perstans was recently described from rDNA ITS1 
sequences. This potential “new species” was recovered from 
human blood samples taken in Gabon, and has provisionally 
been called Mansonella sp. “Deux”.60 A phylogenetic tree, 
constructed with Treecon software70 by the neighbor-joining 
method, shows that Mansonella sp. Deux forms a sister clade 
to standard forms of M. perstans from Brazil and Africa 
(Figure 1). However, further studies should be performed 
to characterize this new species and evaluate its clinical 
significance in humans.60
Epidemiology and distribution
Mansonella parasites are among the most common cause 
of blood parasitemias and are encountered widely across 
Africa and Latin America.3,4,18,23,25,71 M. perstans is consid-
ered the most common of the mansonellosis parasites and 
is endemic in a large portion of sub-Saharan Africa, as well 
as a northern part of the Amazon rainforest stretching from 
equatorial  Brazil to the Caribbean coast of South America, 
with molecular analysis suggesting that the parasite arrived 
in South America relatively recently and most likely as a 
consequence of the slave trade (Figure 2).18,23,25,50 From the 
mid-1920s until the early 1970s, M. perstans was frequently 
recorded as occurring in Papua New Guinea, but there is very 
little primary-source data to support this and no recent survey 
Figure 1 Neighbor-joining phylogenetic tree.
Notes: Tree compares the ITS1 partial sequences of human Mansonella spp. present in the GenBank (accession numbers are indicated in parentheses or with an internal code 
when not submitted to the GenBank). A sequence of L. loa (EU272176) was used as the out-group. Significant bootstrap values are indicated.
Mansonella perstans KJ631373
M. perstans KR080187
M. perstans DQ995498
95
100
83
100
100
100
100
98
M. perstans EU272184
M. perstans KR080188
M. perstans brazil LT623911
Mansonella DEUX KR080185
Mansonella DEUX KR080186
Mansonella streptocerca ISCIII GE183
M. streptocerca ISCIII GE189
M. streptocerca KR868771
Mansonella ozzardi AF228559
M. ozzardi KR952332
M. ozzardi KR952333
M. ozzardi KR952334
M. ozzardi EU272180
Loa loa EU272176
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Figure 2 Distribution of human Mansonella based on published reports before and after the year 2000.
Notes: 1, Before; 2, after.
Abbreviations: Mp, Mansonella perstans; Ms, Mansonella streptocerca; Mo, Mansonella ozzardi.
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data that indicate its occurrence anywhere in the Eastern 
hemisphere outside continental Africa.71 Overall, more than 
100 million people may be infected by M. perstans, and it is 
estimated that 600 million people live at high risk of contract-
ing an infection in Africa alone.23
A strong epidemiological link between banana plantations 
and M. perstans prevalence and parasitic loads was recorded 
more than 100 years ago, before its Culicoides vectors had 
been incriminated in its transmission (Table 1).4,32,72,73 Sharp 
(the man who incriminated Culicoides in the transmission 
of M. perstans) was aware of this epidemiological link and 
presumably also that C. austeni uses banana-tree stumps and 
litter to support its larval development (because this had been 
published in the original description of the C. austeni). It is 
not clear to what extent, if any, the banana-plantation epi-
demiological observation led to elucidation of the life cycle 
of M. perstans.32 Certainly, the epidemiological M. perstans 
studies that have been carried out since then have not provided 
much more significant understanding of the parasites’ biology 
and transmission dynamics. However, they have shown that in 
endemic areas, prevalence of M. perstans infection is higher 
among older age-groups and that men are at more risk of 
infection than women.23–25 Recently, geographic information-
system data obtained from remote satellite imaging have 
been used in conjunction with M. perstans prevalence from 
school surveys to show M. perstans distribution varies with 
diurnal temperature range, vegetation, and cattle density.74 
Epidemiological studies that have tried to link M. perstans 
parasitemias with clinical symptoms have thus far failed to 
detect any significant correlations.23,24
M. streptocerca seems to have a distribution limited to 
continental Africa, where it occurs in the tropical rainfor-
est areas of central and west Africa, as well as in Uganda 
 (Figure 2).4,18,25 Perhaps because the skin-snip biopsies 
required for its epidemiological monitoring are more invasive 
and painful than the blood sampling required for M. perstans 
surveys, or perhaps because blood sampling is simply more 
commonly done for other epidemiological studies, there 
have been fewer epidemiological surveys investigating 
M. streptocerca epidemiology.4,25 As with M. perstans and M. 
ozzardi and many other filarial infections, prevalence rates of 
M. streptocerca are highest in the oldest age-groups studied 
and higher among men than women in endemic areas.21,25,75 
M. streptocerca is transmitted by various species of Culi-
coides and some of the same vector species that transmit 
M. perstans, although there are too few data available to 
evaluate properly whether its distribution is influenced by the 
same ecological drivers as M. perstans (Table 1).15,77,78 The few 
epidemiological studies that have tried to link patent M. strep-
tocerca infections with clinical symptoms have encountered 
similar rates of skin disease among those infected and those 
uninfected in their study areas.75,76
M. ozzardi has a patchy geographic distribution across 
Latin America. It has been recorded from southern Mexico 
to northwestern Argentina, but has not been reported in 
Chile, Uruguay, or Paraguay.3,4,18,25,29 The parasite occurs on 
several Caribbean Islands, and like M. perstans has even 
been recorded in Papua New Guinea, although recent reports 
of its occurrence in the region are notable by their absence 
(Figure 2).4,71 In the Caribbean region, the parasite is trans-
mitted by a diverse range of biting midges from the family 
Ceratopogonidae, whereas in Central and South America it is 
known only to be transmitted by biting midges from the genus 
Culicoides and blackflies from the genus Simulium.3,4,15,29,79–90 
Because of these vectorial differences, it was once thought 
that M. ozzardi from the Caribbean islands and those from 
continental South America might be different species 
(Table 1).85,91 Artificial-infection experiments and the recent 
publication of DNA sequences, however, strongly indicate 
that parasites from the two regions are morphologically, bio-
logically, and genetically near identical, and thus that they are 
most parsimoniously regarded as just one species.2,17,28,48,50,58
Even though the various populations of M. ozzardi are 
best considered as belonging to the same species, it is not safe 
to assume, for example, that the epidemiology of M. ozzardi 
in the Brazilian Amazon region is more or less identical to its 
epidemiology in the Caribbean, because of the great diversity 
of vectors involved.3,4,15,29,79–90 In the Amazon region, although 
it is transmitted by a range of Simulium and Culicoides spe-
cies, the parasite appears to be most commonly transmitted 
by Simulium vectors from the amazonicum species group 
and to have a distribution that follows the riverine breeding 
sites of these Simulium vectors.29,79 In Trinidad, by way of 
contrast, the only known vector is Culicoides phlebotomus 
(which uses sandy-beach breeding sites), and the parasite 
thus has a coastal distribution.15,88
However, it is important to note that vector distribution is 
not the only important driver of M. ozzardi distribution. For 
example, repeated M. ozzardi surveys in the Brazilian Amazo-
nian state of Rondônia have found the area completely devoid 
of the parasite, despite the fact that the region shares a similar 
ecology and blackfly fauna to the neighboring Amazonas state. 
It has been proposed that low levels of human immigration 
may play an important role in the parasite’s failure to establish 
in the region.91 However, data from tourists indicate that M. 
ozzardi infections are easily acquired, and as Rondônia is 
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surrounded by highly endemic areas, migration levels would 
have to be very low indeed for this to be the most important 
factor limiting the parasite’s establishment in the region.19,91–95 
Furthermore, since the first discovery of M. ozzardi, surveys 
have shown that very small isolated foci (in some cases, the 
size of a single village) on numerous islands can sustain 
themselves over prolonged periods, suggesting that even 
low levels of migration could supply a sufficient parasite 
reservoir to allow for the establishment of a new focus if the 
other epidemiological criteria for establishment were met.96 
In Cameroon, it has been proposed that some areas of low 
onchocerciasis endemicity are explained by “zooprophylaxis”, 
whereby exposure to simuliid bites from insects infected with 
cattle parasite Onchocerca ochengi provide something akin 
to natural vaccination.97,98 In light of these observations, the 
recent discovery of highly prevalent zoonotic Mansonella 
parasites in anthropophilic simuliid vectors of the region 
may thus been seen as an alternative explanation as to why 
M. ozzardi has failed to establish in Rondônia.94,98,99
In line with epidemiological studies of other mansonel-
losis, research in the Brazilian Amazon has identified outdoor 
workers, males, and older community members as being at 
elevated risk of developing M. ozzardi parasitemias.101,102 
Importantly too, M. ozzardi parasitemias from this region 
have been shown to be positively correlated with joint pain, 
leg chills, headaches, and corneal lesions.103,104
Pathology and symptomatology of 
mansonellosis
Although mansonellosis has very broad global distribution 
and is almost certainly the most common form of filarial 
parasite infection, little is known about its pathology or 
symptomatology, with most health experts and policy mak-
ers viewing the parasites as largely innocuous and only 
rarely causing mild clinical symptoms.4,5,18,25 However, as 
mentioned, recent studies investigating M. ozzardi infections 
in the Brazilian Amazon have found significant correlations 
between M. ozzardi infections and certain clinical symptoms, 
and other similar epidemiological studies investigating M. 
ozzardi in other regions and M. perstans and M. streptocerca 
have repeatedly failed to correlate clinical symptoms robustly 
with patent mansonellosis infections.101–107
This of course does not mean that mansonellosis is neces-
sarily always completely asymptomatic outside the Brazilian 
Amazon region. Most of the epidemiological studies used 
to investigate symptomatology have had very small sample 
sizes and used diagnostic techniques of low sensitivity (ie, 
light microscopy-based diagnosis of thick blood smears), and 
thus could not be expected to have had sufficient statistical 
power to detect subtle or complex correlations.24,75,76,101–109 
Recent observations suggest that mansonellosis infections 
can influence the human immune system’s response and this 
can influence the development of secondary infections, like 
malaria.110 As mansonellosis infections are chronic and occur 
in many tropical areas where a great number of other infec-
tious diseases also exist, it is possible that the way manson-
ellosis influences other pathogenic infections could actually 
account for a very substantial proportion of its pathogenicity 
and its total disease burden.4,5,18,23,25 At present, however, 
although there have been many accounts of mansonellosis 
parasites co-occurring with other parasites, there have been 
very few accounts about how mansonellosis influences the 
pathogenicity of other infectious diseases.96,110–114
Most symptoms ascribed to M. perstans infections in 
modern scientific literature are based on symptoms that 
have been recorded in case study reports.23,25,44,115,116 As most 
of these reports are based on the treatment of tourists and 
expatriate Europeans and North Americans returning home 
from endemic areas, and not on people who have lived all 
their lives in endemic areas, it is not clear whether the symp-
toms reported from these studies can be used to compile a 
clinical picture that represents all or even most infections 
caused by mansonellosis.23,25,44,116,117 Based on these reports, 
M. perstans can be considered to have little pathogenicity and 
almost always to be asymptomatic, but it can occasionally 
cause itching, joint pains, enlarged lymph glands, and vague 
abdominal symptoms.5,23,25,116,117
High-level eosinophilia are regularly observed in some 
but not all patients with M. perstans infections, probably 
as a consequence of the body’s reaction against the adult 
worm, rather than against microfilariae.118 M. perstans is also 
reported to be able to induce dermatological symptoms like 
the Calabar swellings of loiasis, fever, headaches, and pain 
in bursae and/or joint synovia or in serous cavities.23,25,44,118 
There has also been ocular pathology ascribed to M. perstans 
in which yellowish nodules develop in the bulbar conjunctiva; 
it has been reported that this pathology can on occasion pro-
voke edema of the eyelids and proptosis.7,118 This pathology, 
which has been described as a rare clinical manifestation of 
M. perstans infections caused by adult M. perstans migrat-
ing to the eye, is commonly referred to as “bulge” or “bung” 
eye disease.7,118 Whether, however, this pathology is caused 
by M. perstans or a zoonotic parasite from the Mansonella 
genus is not presently clear.7,118 Certainly, it is not uncom-
mon for zoonotic filarial infections to have ocular clinical 
manifestations of this type.7,8
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In addition to showing that M. ozzardi infections are 
associated with joint pain, leg chills, headaches, and corneal 
lesions, epidemiological studies have also added support to 
the notion that M. ozzardi infections are mostly asymptom-
atic.101–105 Case reports from tourist-acquired infections have 
also suggested that M. ozzardi infections can cause fatigue, 
respiratory problems, dermal swellings, and itching; however, 
evidence that such symptoms occur regularly in endemic 
settings is still lacking.19,95
There have been very few studies of M. streptocerca 
infections. From what data are available, however, it is 
clear that infections with this parasite are very often (if not 
exclusively) asymptomatic.4,5,21,22,25,75 However, it has been 
proposed that infections cause various types of dermatologi-
cal symptoms in the shoulders and thorax, where the parasite 
is mostly encountered.4,5,21,22,25,75 Hyperpigmented macules 
have been attributed to infections occurring in the Demo-
cratic Republic of the Congo, but have not been reported 
everywhere the parasite is found, including Uganda, and 
thus some authors have cautioned against their attribution to 
M. streptocerca infections.21,22,75 Chronic papular dermatitis 
has been encountered in most M. streptocerca-endemic areas 
and has been reported to be cleared from patients successfully 
treated for M. streptocerca infections.75 However, in endemic 
areas where epidemiological studies have been performed, 
chronic papular dermatitis is no more common in those 
patients who have detectable M. streptocerca in their skin 
snips than in those that do not, and thus at present there is no 
statistically robust evidence to support the parasites causing 
any symptoms at all.4,5,21,22,25,75
Diagnosis
Clinical diagnosis
As indicated in the previous section, very few clinical 
symptoms have been robustly linked to mansonellosis in 
general,4,5,25 and at present there is robust evidence to support 
the notion that only M. ozzardi infections cause any clini-
cal symptoms at all.103,104 Therefore, it is near impossible to 
make a reliable clinical diagnosis of mansonellosis, even 
for M. ozzardi-caused mansonellosis. This is because most 
of the symptoms that have statistically robust associations 
with mansonellosis, such as joint pain, are so aspecific, dif-
ficult to score, and caused by numerous other pathogens that 
occur in mansonellosis endemic region as to be of almost no 
utility at all.101–103 Even the potential of corneal lesions for 
clinical diagnosis is limited, because although they are quite 
a perceptible physical symptom, they are quite aspecific, 
occurring in both infected and uninfected individuals from 
M. ozzardi-endemic areas. Furthermore, corneal lesions 
are not manifest in everyone who is infected or even occur 
everywhere that M. ozzardi occurs (eg, there are no reports 
of M. ozzardi causing corneal lesions anywhere in the Carib-
bean area).103,104 In summary, it is presently impossible to use 
the clinical presentation of mansonellosis to make a reliable 
diagnosis of the disease.
Parasitological diagnosis
Traditional parasitological diagnosis, which is based on 
direct observation of a causative parasite, is still the most 
common way mansonellosis infections are diagnosed. It is 
performed by the detection and identification of sheathless 
Mansonella microfilariae in the skin or blood at any time of 
day or night.4,5,18,25,30 Detection of skin-dwelling microfilariae 
is usually done by examination of ~1.5 mg (~2 mm diam-
eter) skin-biopsy (skin-snip) samples, taken with a Walser 
or Holth corneoscleral punch.4,5,18,25,30,119 The skin-snip test 
requires that a skin biopsy be taken from areas of presumed 
optimal microfilariae density, and this varies depending on 
geographic location. Blood samples used for mansonellosis 
diagnosis are often taken from peripheral blood samples by 
way of finger pricks, although venous blood samples can also 
be used for this purpose.4,5,18,25,30,119
When microfilariae are present in high numbers in the 
patient’s blood, as is often the case in endemic areas, they 
may be easily found and identified in thick or thin blood 
smears stained with Giemsa or hematoxylin.5,25,30,119 Skin 
snips are usually incubated in water or saline, and the emer-
gent microfilariae can be stained on microscope slides, but 
in fresh unstained wet preparations of skin snips, the way in 
which the microfilariae move can also help with their iden-
tification. The main diagnostic microfilariae characteristics 
can be found in Table 1.25,29,30,38,119 Morphologically, the most 
important features to identify microfilariae in blood smears 
stained with Giemsa are size and shape of the tail, presence 
or absence of a sheath, and the arrangement of terminal 
nuclei (in the tail).18,25,30,38,119 All Mansonella microfilariae 
are unsheathed, and for diagnostic purposes are treated as 
aperiodic.5,18,25,30,38,120
The microfilariae of M. perstans are reported to be 
200×4–5 μm, to have blunt rounded tails, and to have nuclei 
extending to the tips of their tails (Figure 3). M. perstans 
is easily distinguishable from other blood-dwelling micro-
filariae, which have overlapping distributions (Loa loa or 
Wuchereria bancrofti), by their being smaller, their lack of 
an enveloping sheath, and their tail features (their terminal 
nuclei are bigger than the other microfilariae).5,18,25,30,119
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M.  streptocerca microfilariae are smaller and thinner 
(180–240×3–5 μm) than Onchocerca volvulus, and have 
hook-shaped tails with nuclei that extend to the end (no nuclei 
are seen in the pointed tail region of O. volvulus microfilariae) 
(Figure 3).5,18,25,30,119 In wet mounts, live M. streptocerca microfi-
lariae are usually less motile than those of O. volvulus.5,119 With 
these morphological descriptions, the two filariae should be eas-
ily distinguished. In the past, however, in some countries, such 
as Uganda, M. streptocerca and O. volvulus have been confused, 
despite the clear morphological differences between them.30,39,75
The microfilariae of M. ozzardi are reported to be 163–
203×3–5 μm, with long thin pointed tails and body nuclei that 
do not extend to the tips of their tails.2–5,30,38 As they can locate 
in both the blood and skin, from a public health perspective it 
is most important that the microfilariae can be differentiated 
from W. bancrofti and O. volvulus.2–5,25,30,38,119–122 The microfi-
lariae of M. ozzardi can be easily distinguished from those of 
W. bancrofti by virtue of being smaller and having no sheath 
(Figure 3).5,18,25,30,120 Living microfilariae of M. ozzardi can be 
obtained from skin snips and are not easily differentiated from 
O. volvulus by movement.2–5,25,30,38,119–122 Their morphology is 
similar to the pathogenic O. volvulus, and it is especially impor-
tant to distinguish these two species where they are sympatric, 
eg, in Amazonia onchocerciasis focus. Although morphologi-
cal characters can be used to discriminate these two species,38 
difficulties have led to false reports of new onchocerciasis foci 
and continue to pose a problem for onchocerciasis epidemio-
logical monitoring in the Amazonia focus, which is now the 
last Latin America onchocerciasis focus where transmission 
is considered to be ongoing.30,38,40,99,123,124
Inmunodiagnosis
Immunological methods involve detection of either antibody 
or antigen. When a filarial parasite immunodiagnostic assay 
is detecting antibodies, enhanced specificity is often achieved 
by assessment of IgG4 rather than total IgG, as IgG4 antibod-
ies are significantly elevated in microfilaria-positive individu-
als.125 Although there is presently no effective antigen- or 
antibody-detecting immunological assay for diagnosis or 
epidemiological monitoring of mansonellosis infections, both 
kinds of tools have been developed for onchocerciasis and 
lymphatic filariasis disease-control programs, and have been 
tested for cross-reactivity with mansonellosis sera.4,25,51,126–128 
The reliability (specificity and sensitivity) of these immuno-
diagnostic tools for lymphatic filariasis and onchocerciasis 
has not been fully characterized for all of the tests, and the 
best-understood and most reliable tests are not necessarily the 
most convenient, and thus whether they should be employed 
to assist with mansonellosis research and diagnostics is 
questionable.4,51,124,126–128 However, two recently published M. 
perstans studies used generic immunological filariasis assays 
to support light-microscopy-based diagnoses.116
Figure 3 Comparison of the three agents causing mansonellosis illustrating the morphological characteristic of each microfilariae.
Notes: (A) M. perstans microfilariae seen in Giemsa-stained thick blood smear with blunt rounded tail and nuclei extending to the tip of the tail: M. perstans parasite from 
São Gabriel da Cachoeira (Amazonas state, Brazil) (A1); African M. perstans (A2). (B) M. streptocerca microfilariae from a skin-snip fixed and Giemsa-stained showing the 
characteristic hooked tail. (C) M. ozzardi microfilariae from São Gabriel da Cachoeira (Amazonas state, Brazil) stained with Giemsa (C1, C2).
Mansonella perstansA
A1
A2
C1 C2
B
C
50 µm
50 µm 100 µm 50 µm
50 µm
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Molecular diagnosis
Although DNA-based diagnostic tools can be used to detect 
and identify all of the known human filarial parasites, their 
most important utility to public health is their ability to differ-
entiate skin infections of M. streptocerca and M. ozzardi from 
O. volvulus skin infections and M. perstans parasitemias from 
L. loa and W. bancrofti parasitemias.51,126 DNA-based tech-
niques for filarial parasite detection and identification have 
been proven to be both sensitive and specific, and have now 
begun to replace light-based microscopy in epidemiological 
surveys of mansonellosis.4,49,51,52,114,129–133 Molecular diagnosis 
may be used to detect microfilariae in both peripheral blood 
and skin biopsies, and adult worms in other tissues.4,51,52,114,129 
PCR-based amplification of species-specific target sequences 
allows increasing diagnostic sensitivity compared with 
microscopic methods and reliable differentiation of samples 
taken from individuals living in coendemic areas.51,52,114,127 
In 2010, Tang et al53 developed a popular nested PCR that 
could detect any form and life stage of filariae in the human 
host or vector. This assay uses universal filariae PCR primers 
to amplify a variable portion of filarial parasite ribosomal 
ITS1 DNA, and allows for the subsequent identification of 
species based on the size of the amplified fragment. This 
technique is used in conjunction with gel electrophoresis and/
or Sanger sequencing, and allows for the characterization of 
previously unknown species (the M. perstans variant Deux 
was found in this way).49,53,114,129 Recently, this rDNA ITS1-
based method was turned into a single-step diagnostic by 
adapting it for real-time PCR.113,131 This new assay allows for 
the identification of filarial parasite without the need for gel 
electrophoresis or Sanger sequencing, but does require more 
expensive reagents and infrastructure than standard PCR 
assays, and does not directly allow for the characterization 
of novel or unexpected filarial species.113,131 Other methods 
(such as PCR–restriction-fragment-length polymorphism 
[RFLP]) that do not allow for the characterization of novel 
or unexpected filarial species, but require less infrastructure 
to support them and can differentiate a broad range of filarial 
species using universal primers with a combination of PCR 
and RFLP, have also been reported.132,133 Despite requiring 
less complex infrastructural support than alternative methods, 
PCR-RFLP assays still require access to PCR reagents and 
a PCR machine, which can be a limiting factor for filarial 
parasite epidemiological studies.
Last year, the first DNA-detecting loop-mediated iso-
thermal amplification (LAMP) filarial parasite assays were 
reported.134,135 Although these assays have not yet been 
rigorously tested in the field or developed for the detection 
of Mansonella parasites, there is no theoretical reason they 
could not be adapted for mansonellosis research.134,135 Requir-
ing almost no infrastructural support, LAMP assays are a 
particularly appealing diagnostics option for research stud-
ies that need to be done in resource-limited settings.51,134,135 
For this reason, these new LAMP assays can be seen as a 
welcome development for filarial parasite research in gen-
eral and an interesting new tool of research to develop for 
mansonellosis.51,134,135
Treatment
Among the three types of human mansonellosis, the one 
caused by M. perstans is usually regarded as the most dif-
ficult to treat.4,18,23,25,116 Treatment studies have provided 
conflicting results, and there are at present no international 
guidelines on best treatment.18,23,25,67,116,136–140 Few studies have 
recruited sufficient patients to provide statistically robust 
results to support their conclusions, and many are based on 
the treatment of one or two European or North American 
expatriates or tourists returning from endemic areas, who 
may not respond to treatments in the same way as residents 
of endemic areas.4,23,25,116 The existence of genetically distinct 
strains of M. perstans (like Deux or strains that lack Wolba-
chia) complicates the formulation of treatment guidelines 
further, as it also possible that the efficacy of therapeutics 
varies between these strains.60,66
In one of the more robust M. perstans mansonellosis 
studies hitherto, conducted in the south of Chad, symptom-
atic subjects with evidence of M. perstans microfilariae in 
the peripheral blood were divided in groups and tested with 
the antiparasitic drugs diethylcarbamazine (DEC), mebenda-
zole, ivermectin, praziquantel, thiabendazole, and DEC plus 
mebendazole.137 DEC plus mebendazole proved to be the most 
effective antiparasitic treatment to reduce microfilaremia, and 
it is now one of the most used. Thiabendazole was second, 
with a single treatment significantly reducing microfilariae in 
blood. Ivermectin and praziquantel did not prove to be useful 
in the treatment of M. perstans infections. Mebendazole alone 
was seen to be a good alternative treatment and appeared to 
be more active than DEC alone in eliminating the infection.137
In another study carried out in Uganda, ivermectin alone, 
albendazole alone, and the two drugs in combination were 
assessed in three groups infected with M. perstans.138 In 
this study, in concordance with the aforementioned study, 
microfilarial levels were unaffected by ivermectin or alben-
dazole treatment when these drugs were used alone. Van den 
Enden et al136 reached the same conclusion about albendazole 
treatment after finding that treatment had not decreased 
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 microfilarial counts after a median follow-up period of 45 
days. However, it has been found that when these drugs (iver-
mectin + albendazole) are used in combination, microfilarial 
loads decrease slightly after treatment.136,139
In contrast to conventional anthelmintic treatments, 
doxycycline has proved to be excellent, effective, and safe in 
the treatment of M. perstans infections.4,67,116,139,140 However, 
the course of treatment over 6 weeks, which is necessary for 
this type of therapy, probably makes it impractical for con-
trol programs, although the fact that it appears to be curative 
makes it a very desirable therapeutic for travel medicine.4,65,67 
However, doxycycline treatment may not work on all M. 
perstans infections, as there is evidence of subspecies genetic 
diversity among M. perstans parasites and it is presently 
unclear whether all M. perstans strains harbor the Wolbachia 
endosymbiont.60,66 This treatment’s safety profile and all 
hitherto-published results on its efficacy, however, suggest 
that doxycycline treatment should be the first-choice treat-
ment for perstans mansonellosis wherever it can be feasibly 
administered.7,67,115,116
The use of ivermectin for treating M. ozzardi has proven 
to be very effective against microfilariae in a number of stud-
ies.3,23,25,29,139–143 A single dose of ivermectin given to infected 
adults was seen to reduce microfilariae densities and provide 
both short- and long-term reductions in M. ozzardi micro-
filaraemia.29,142,143 Adverse events, however, have been seen 
in some patients with M. ozzardi treated with  ivermectin.143 
Two elderly patients from Argentina developed serious 
adverse events that resembled a Mazzotti reaction following 
ivermectin administration, although the patients recovered 
without sequelae after 2–3 days.143 DEC has little or no effect 
on microfilariae of M. ozzardi.3
Because of its effectiveness in the treatment of M. ozzardi, 
ivermectin has been used as a mansonellosis control tool in the 
Brazilian Amazon region.139,140 The recent discovery of M. per-
stans in the northern regions of the Brazilian Amazon, however, 
suggests that this approach will not be effective everywhere.50 
As M. ozzardi are also known to harbor the endosymbiotic 
Wolbachia, it maybe that mansonellosis in this region can be 
tackled with a single anti-Wolbachia treatment regime using 
an antibacterial agent.3,4,144 Although the six-week treatment 
course required for doxycycline-based therapies makes them 
impractical for filarial parasite-control programs, new anti-
Wolbachia therapeutics with far shorter treatment courses 
(of 3–7 days) are in the pipeline and could make appealing 
treatment options throughout the whole Amazon region and 
beyond.145–148 However, it is important that before such a 
measure is employed, efforts are made to determine whether 
this treatment interrupts transmission (like ivermectin treat-
ment does). This is important to establish, as anti-Wolbachia 
treatments are not thought to kill Mansonella microfilariae 
directly and may thus not interrupt mansonellosis transmis-
sion as effectively as some of the alternative options.67,115,117
DEC and ivermectin have been used with good effect to 
treat M. streptocerca infection.4,18,25,39,149 Fischer et al found 
that a single dose of 150 μg/kg body weight of ivermectin 
suppresses microfilaria for a year or more, with 46% of 
individuals displaying no detectable microfilaria on skin 
biopsy 1 year after treatment.149 The most common treatment 
for M. streptocerca infections is DEC given at 6 mg/kg/day 
orally in three doses for 12 days.139,140 At present, it is unclear 
whether M. streptocerca harbors a Wolbachia endosymbiont 
like M. ozzardi and M. perstans.4,66 If it does, the possibility of 
using an anti-Wolbachia therapeutic like doxycycline for the 
treatment of M. streptocerca should also be investigated.4,139,140
Global burden
The high prevalence of asymptomatic cases and the lack of a 
universally agreed clinical profile for any of the three forms 
of mansonellosis infection has left many researchers in the 
field reluctant to even describe mansonellosis as a disease, 
with some authors conspicuously avoiding the word “disease” 
and some preferring to use the term “condition”.1–5,18,25 This 
prevailing perspective of mansonellosis as a benign parasitic 
infection with little or no direct effect on patients’ well-being 
has left mansonellosis research trapped in a vicious circle of 
neglect. Mansonellosis research is unable to generate robust 
clinical data exactly because of the present paucity of robust 
clinical data makes funding mansonellosis research difficult 
for research councils to justify.
In addition to this, the symptoms currently directly 
attributed to mansonellosis are difficult to utilize in the 
modern metric systems used to assess disease burden and in 
the allocation of research funding. From the data presently 
available, it is impossible to assign any mortalities directly 
to mansonellosis infection and even difficult to assign the 
disability-adjusted life-years or years lost to disability, 
which have been used so effectively in the advocacy of 
attracting research funding to the 13 core neglected tropical 
diseases.150–152 Recent surveys of the global burden of disease 
commissioned by a major tropical disease research fund 
have omitted mansonellosis from their analyses, which has 
surely resulted in the disease receiving a neglect that may 
be inappropriate.151–154
Even without a recognized disease burden, however, 
it is still clear that mansonellosis has an important role in 
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global health by indirectly interfering with the effectiveness 
of control programs targeting more serious diseases.4,29,53 As 
mentioned earlier, the similarity between the microfilariae of 
O. volvulus with M. streptocerca (in Africa) and M. ozzardi 
(in Latin America) encountered in skin snips has led to false 
reports of onchocerciasis foci and misallocation of precious 
onchocerciasis-control resources.39,40,120 Although we are 
unaware of published accounts of M. perstans in skin being 
confused with O. volvulus, the recent molecular detection of 
M. perstans DNA in skin snips on the island of Bioko (Equato-
rial Guinea) suggests that it could potentially have happened 
without being detected.113 Similarly, mansonellosis parasites 
have been shown to interfere with some onchocerciasis immu-
nodiagnostic assays and are suspected of interfering with the 
reliability of others.51,120,124 In relation to lymphatic filariasis 
control, false-positive results with the Binax Now filariasis 
immunochromatographic test have recently been recorded in 
several independent studies carried out in central Africa. It is 
presently argued that the observed cross-reactivity is entirely 
attributable to L. loa infections, but a role for M. perstans in 
cross-reactivity has not yet been definitively ruled out.128,151,152
Beyond mansonellosis’s direct and indirect (by raising 
morbidity in coinfection cases) disease burden and beyond 
even its role in interfering with the diagnostics used in other 
neglected tropical disease-control planning, it could also be 
negatively affecting global health by negatively impacting 
the efficacy of vaccine programmes.154–156 It has been shown, 
for example, that certain lymphatic filariasis infections can 
affect the efficacy of some vaccines (including tuberculosis 
and HIV vaccines), and thus it is quite possible that mansonel-
losis infections could have a similar effect.156 For this reason, 
some authors have discussed the possibility of auxiliary 
“deworming” programs to accompany vaccine programs as 
a way of potentially improving their efficacy.154–156 Given the 
importance of vaccines as tools for infectious disease con-
trol and the extremely high prevalence of mansonellosis in 
infectious disease hot spots, the influence mansonellosis has 
on the efficacy of vaccine programs may in fact be the most 
important impact mansonellosis has on global health.154–156
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